Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Astellas.

Advances in™ Infectious Diseases: Overcoming Fungal Infections: Prophylaxis, Diagnosis, and Treatment Strategies to Improve Patient Outcomes

Release Date: October 31, 2019
Expiration Date: October 31, 2020
Media: Internet - based

Activity Overview

Invasive fungal infections (IFIs) contribute to substantial morbidity and mortality in immunocompromised individuals. The incidence of these infections is increasing, in part by the growing number of immunocompromised patients, including those with neutropenia, HIV, chronic immunosuppression, diabetes mellitus, hematological malignancies, transplantation, severe burns, and major surgery. Treatment requires early suspicion and is difficult because just a few antifungal agents are available, most agents have adverse effects, and some organisms have developed resistance to antifungal agents. This activity will provide clinicians with insights into IFI incidence and diagnostic methods and the management of these infections.

Benefits of Participating

  • Learn about strategic measures to improve on care of patients at risk of invasive IFI, including ways to improve or implement strategies that may reduce the risk
  • Increase awareness of treatment measures for patients at risk or those who have acquired these infections within their immunocompromised state
  • Learn about best practices to enhance clinical decision making when choosing among treatment options available for patients who need emergent management of IFI

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Astellas.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • In order to receive a CME/CE Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE Certificate upon completion of these steps.

Target Audience

This online educational activity is directed toward primary care physicians, infectious disease specialists, nurse practitioners, and physicians’ assistants who are involved in the treatment of fungal infections.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify at-risk populations for IFI and IFI-related complications
  • Review effective diagnostic testing for IFI
  • Select an individualized plan of care based on current guideline recommendations, including prophylactic therapy in high-risk populations

Faculty, Staff, and Planners’ Disclosures

Faculty

Peter G. Pappas
Peter G. Pappas, MD, FACP
Professor of Medicine
Director, Mycoses Study Group
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL

Disclosures: Grant Research Support: Amplyx, Astellas, Cidara, IMMY, Merck, Scynexis,; Consultant: Amplyx, Cidara, Scynexis.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER®, as a sponsor accredited by the ACCME, to ensure fair balance, independence, objectivity, and scientific rigor in all its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician to provide diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®. or the company that provided commercial support.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By